European Partnership on One-Health Anti-Microbial Resistance (OH AMR)
The One Health Antimicrobial Resistance (OH AMR) Partnership aims to support the coordination and alignment of AMR research activities and funding in Europe and beyond. The main goal is to contribute to achieving the objectives of the European One Health Action Plan against AMR and the World Health Organization (WHO) Global Action Plan on AMR, by reducing the threat of AMR and contribute to achieving the objectives of the Health Emergency Preparedness and Response Authority (HERA).
Under the 2023-2024 work programme, one call is forthcoming.
Partnership on One-Health Anti-Microbial Resistance (OH AMR)
- European Commission’s Directorate General for Research and Innovation (DG RTD)
OH AMR is a partnership under Horizon Europe.
The total indicative budget for the duration of OH AMR is EUR 100 million. In addition, EUR 100 million are expected to come from the partnership’s partners.
Unknown
Grants, other parties are allowed to participate by giving in-kind contributions to the beneficiaries but will not be regarded as formal recipients of EU funding. However, depending on the funding organisation within the call, a contribution towards the project can be required.
Not clearly specified at this stage.
The partnership should contribute to the priorities set in the European One Health Action plan to fight AMR that provides a European framework with actions focused on areas with the highest added value for Member States, including boosting research development and innovation.
Applicants based in the following geographical areas are eligible for funding:
- European Union Member States
- Countries associated to Horizon Europe
- Low- and middle-income countries (LMICs)
- Other third countries – United States
2023 – 2027
The indicative timeline for evaluation and grant agreement, described in Annex F of the Horizon Europe Work Programme 2023-2024, is as follows:
- Information on the outcome of the evaluation: Around 5 months from the deadline for submission
- Indicative date for the signing of grant agreements: Around 8 months from the deadline for submission
For two-stage calls, the timing is different (for the evaluation result: around 3 months from the deadline for submission for the first stage and around 5 months from the deadline for submission for the second stage; for signature of the grant agreement: around 8 months from the second stage deadline for submission).
Not clearly specified
Not clearly specified
Call for proposals here
Forthcoming
- Planned opening date: 25 April 2024
- Deadline date: 25 September 2024